SCHEMBL20160906

SCHEMBL20160906

Cc1ccc(C(=O)N2CCN(C)CC2)nc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.66
TNKS O95271 3/20 0.50
HRH4 Q9H3N8 4/20 0.48
HRH3 Q9Y5N1 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
PDE10A Q9Y233 1/20 0.47
DRD3 P35462 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
MTOR P42345 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
POLB P06746 1/20 0.45
KDM4A O75164 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL46306 0.87 TDP1 (0.65) TDP1HRH3SMN1; SMN2L3MBTL1PDE10A
SCHEMBL30341672 0.87 TDP1 (0.65) TDP1HRH3SMN1; SMN2L3MBTL1PDE10A
SCHEMBL10329801 0.87 TDP1 (0.65) TDP1HRH3SMN1; SMN2L3MBTL1PDE10A
SCHEMBL16408483 0.85 TDP1 (0.63) TDP1HRH3SMN1; SMN2L3MBTL1PDE10A
SCHEMBL16546002 0.85 TDP1 (0.63) TDP1HRH3SMN1; SMN2L3MBTL1PDE10A
SCHEMBL2377708 0.83 POLB (0.54) TDP1TNKSHRH4HRH3SMN1; SMN2
SCHEMBL3398915 0.83 CCR8 (0.48) TDP1TNKSHRH4SMN1; SMN2L3MBTL1
SCHEMBL7877444 0.83 SMN1; SMN2 (0.70) TDP1SMN1; SMN2PDE10AMTORNPC1
SCHEMBL12286062 0.83 TDP1 (0.60) TDP1HRH4SMN1; SMN2L3MBTL1PDE10A
SCHEMBL25498357 0.81 SMN1; SMN2 (0.56) TDP1TNKSHRH4SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086589-A1 1,5,7-TRI-SUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES 上海海雁医药科技有限公司 2018-05-17 WO disclosed